MORE INFORMATION

Useful clinical study websites
This document provides a summary of the main results of the study. It includes information about the side effects that happened in the study and the results of the questions the researchers wanted to answer.

A full report may be available to read at the following clinical trial register: www.clinicaltrials.gov
Use the study number NCT02598583 to search for more information on this website.

Further studies
Several studies investigating ravulizumab for the treatment of PNH are either currently running or completed. Please follow the links below to find out more information.
- PNH Registry
- ALXN1210-PNH-201: Multiple ascending-dose study of ravulizumab in adults with PNH
- ALXN1210-PNH-301: Ravulizumab versus eculizumab in adults with PNH
- ALXN1210-PNH-302: Adults with PNH currently treated with eculizumab
- ALXN1210-PNH-303: Ravulizumab administered subcutaneously versus intravenously
- ALXN1210-PNH-304: Children and adolescents with PNH

Protocol, ALXN1210-PNH-103

SPONSOR CONTACT INFORMATION:
United States, 1-888-765-4747